Health

Urgent Call for Papers: Exploring Bleeding Disorders During Pregnancy

2025-09-19

Author: Mei

Meet the Driving Forces Behind the Research

Get ready to dive into groundbreaking research on bleeding disorders in pregnancy, spearheaded by two prominent experts in the field!

Dr. Christian Haslinger: The Pioneering Obstetrician

Leading the charge is Dr. Christian Haslinger, a Professor and Senior Attending Obstetrician at the University Hospital Zurich. His significant research revolves around postpartum hemorrhage (PPH). He's not just any doctor; he's the brains behind the SWIFT-Trial, a major study funded by the Swiss National Science Foundation. This trailblazing trial investigates the effects of early coagulation factor XIII administration for women battling postpartum hemorrhage. Dr. Haslinger has a knack for innovation — from comparing carbetocin and oxytocin during C-sections to exploring new techniques for treating uterine atony.

Dr. Wolfgang Korte: The Hematology Expert

Joining him is Dr. Wolfgang Korte, a stalwart in Hematology and Laboratory Medicine. With a wealth of experience, including a professorship at the University of Bern and founding the Centre for Laboratory Medicine in St. Gallen, Dr. Korte brings his extensive expertise to the team. His focus spans from perioperative coagulation management to cutting-edge research involving automation and AI in medicine. A member of several medical societies, he has dedicated years to research on factor XIII and plays a crucial role in the SWIFT study's steering committee.

Why This Research Matters?

Bleeding disorders in pregnancy can pose severe risks to both mothers and newborns. This collaborative effort, underpinned by deep expertise, aims to shed light on critical interventions that can save lives. With the combined efforts of these leaders in obstetrics and hematology, valuable insights into the management of bleeding during and after pregnancy are on the horizon.

Get Involved!

Researchers, healthcare professionals, and interested parties are encouraged to contribute their findings and ideas. This is a pivotal moment to influence the understanding and treatment of bleeding disorders in pregnancy, making it crucial for medical experts to share their knowledge through this call for papers.